Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Jun 24 | XLO Xilio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.05 | 50,000 | 52.50 k | 50,000 |
15 May 24 | MNKD MannKind | RSU Common Stock, $.01 Par Value | Grant | Acquire A | No | No | 0 | 35,047 | 0.00 | 35,047 |
6 Oct 23 | HZNP Horizon Therapeutics Public | Ordinary Shares | Sale back to company | Dispose D | Yes | No | 116.5 | 23,638 | 2.75 mm | 0 |
6 Oct 23 | HZNP Horizon Therapeutics Public | Ordinary Shares | Sale back to company | Dispose D | No | No | 116.5 | 33,156 | 3.86 mm | 0 |
6 Oct 23 | HZNP Horizon Therapeutics Public | RSU Ordinary Shares | Sale back to company | Dispose D | No | No | 0 | 4,016 | 0.00 | 0 |
6 Oct 23 | HZNP Horizon Therapeutics Public | Stock Option Ordinary Shares | Sale back to company | Dispose D | No | No | 13.87 | 32,161 | 446.07 k | 0 |
6 Oct 23 | HZNP Horizon Therapeutics Public | Stock Option Ordinary Shares | Sale back to company | Dispose D | No | No | 12.19 | 8,150 | 99.35 k | 0 |
29 Sep 23 | HZNP Horizon Therapeutics Public | Ordinary Shares | Option exercise | Acquire M | No | No | 12.19 | 11,850 | 144.45 k | 33,156 |
29 Sep 23 | HZNP Horizon Therapeutics Public | Stock Option Ordinary Shares | Option exercise | Dispose M | No | No | 12.19 | 11,850 | 144.45 k | 8,150 |